IT EN Trainings Job opportunities FAQ-Covid Sign Up Reserved area Company Products Bibliography News&Media Contacts Downloads Home News&Media DIESSE LAUNCHES THE SARS-CoV-2 “NEUTRALIZING” Ab, AN IMPORTANT TEST FOR MEASURING VACCINE EFFECTIVENESS DIESSE LAUNCHES THE SARS-CoV-2 “NEUTRALIZING” Ab, AN IMPORTANT TEST FOR MEASURING VACCINE EFFECTIVENESS FRIDAY 29 JANUARY 2021 Siena, 29 January 2021 – DIESSE Diagnostica Senese has released a new quantitative testing kit. The SARS-CoV-2 “Neutralizing” Ab, as anticipated in December, will be available on over 2000 Chorus platforms worldwide. The test determines the quantity of neutralizing antibodies, capable of protecting us from the SARS-CoV-2 virus, found in serum samples. Head of Biotechnology Research at Diesse, Alessandra Brogi, hopes that “the kit can be used on a large scale to verify in a quantitative and standardised way whether or not patients who have either received the vaccine or have simply contracted COVID in the past, are in effect immune to the SARS-CoV-2 virus”. This new test adds to the range of Diesse kits currently available. The full range of serological and antigenic kits provide for COVID-19 testing during the different stages of the disease, and result in a complete diagnostic solution. Copyright © 2021 DIESSE Diagnostica Senese Spa P.IVA: 05871140157 Società soggetta all’attività di direzione e coordinamento di Duomodiag S.r.l. Cookie Privacy Company data Address: Via Strada dei Laghi 35-39, Z.I. Casone, Ingresso 6 Monteriggioni, 53035 Siena, IT - GPS 43.4010209,11.1768094 E-mail customercare@diesse.it CLOSE Use of cookies We use cookies, third party cookies in order to improve our services. Browsing the site, you accept the use of cookies by us. For more information or to find out how to change the configuration, please see our page policy on cookies